[Report on the clinical testing of the Sembrina--Saltucin. Drug combination for the treatment of hypertension].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D004232:Diuretics / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000097:blood / Q000188:drug therapy; D008750:Methyldopa / Q000008:administration & dosage* / Q000494:pharmacology; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D011188:Potassium / Q000097:blood; D014508:Urea / Q000097:blood
D001786:Blood Glucose; D004232:Diuretics; D008750:Methyldopa; D014508:Urea; D003404:Creatinine; D009584:Nitrogen; D011188:Potassium
Bericht über die klinische Prüfung von Sembrina--Saltucin. Arzneimittelkombination zur Behandlung der Hypertonie.